Found: 36
Select item for more details and to access through your institution.
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome.
- Published in:
- Systematic Reviews, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s13643-018-0805-7
- By:
- Publication type:
- Article
Characteristics and Outcome of Periengraftment Respiratory Distress Syndrome after Autologous Hematopoietic Cell Transplant.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1627, doi. 10.1111/bjh.19677
- By:
- Publication type:
- Article
Venetoclax plus hypomethylating agents in DDX41‐mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 171, doi. 10.1111/bjh.19105
- By:
- Publication type:
- Article
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 279, doi. 10.1111/bjh.18850
- By:
- Publication type:
- Article
Characteristics of patients with myelodysplastic syndrome with balanced translocations.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 244, doi. 10.1111/bjh.16551
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
A phase II study of combination d aunorubicin, cytarabine (A ra‐c), and nilotinib (TA signa) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 472, doi. 10.1002/ajh.26831
- By:
- Publication type:
- Article
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
- By:
- Publication type:
- Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
- By:
- Publication type:
- Article
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 211, doi. 10.1007/s00277-022-05016-1
- By:
- Publication type:
- Article
Autoimmune manifestations in STAG2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2785, doi. 10.1007/s00277-022-04995-5
- By:
- Publication type:
- Article
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 1, p. 51, doi. 10.1111/ejh.14132
- By:
- Publication type:
- Article
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.
- Published in:
- American Journal of Clinical Pathology, 2022, v. 158, n. 4, p. 530, doi. 10.1093/ajcp/aqac083
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00777-4
- By:
- Publication type:
- Article
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
- By:
- Publication type:
- Article
A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 11, p. 1, doi. 10.1038/s41408-021-00573-6
- By:
- Publication type:
- Article
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 5, p. 121, doi. 10.1007/s11899-023-00699-3
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1511, doi. 10.1002/ajh.25978
- By:
- Publication type:
- Article
Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
- By:
- Publication type:
- Article
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
- Published in:
- Transplant Infectious Disease, 2016, v. 18, n. 6, p. 913, doi. 10.1111/tid.12612
- By:
- Publication type:
- Article